
|Articles|June 24, 2009
Gene therapies
Ocular applications of gene therapies are increasing, as is our understanding of the molecular pathogenesis of glaucoma.
Advertisement
Ocular applications of gene therapies are increasing, as is our understanding of the molecular pathogenesis of glaucoma. In the Survey of Ophthalmology (Vol 54, No 4) Xuyanf Lie et al., look at Gene Therapy Targeting Glaucoma: Where Are We? and concludes: "Improvements in gene delivery techniques, refinement of vector construction methods, and development of better animal models combine to bring this potential therapy closer to reality."
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
2026 Nobel Prize in Physiology or Medicine awarded for optogenetics discovery
2
Oku Digital Health launches from Topcon to link eye care, primary care
3
EURETINA 2026: Optogenetic therapy MCO-010 aims to restore vision in advanced macular disease
4
Real-world VOYAGER data on faricimab in nAMD, DME, RVO at EURETINA 2026
5



















